ETH Zürich, Physical Chemistry, Vladimir-Prelog-Weg 2, 8093 Zürich, Switzerland.
Institut de Biologie et Chimie des Protéines, Bases Moléculaires et Structurales des Systèmes Infectieux, Labex Ecofect, UMR 5086 CNRS, Université de Lyon,7 passage du Vercors, 69367 Lyon, France.
Trends Biochem Sci. 2017 Oct;42(10):777-787. doi: 10.1016/j.tibs.2017.08.001. Epub 2017 Sep 12.
Amyloid structures at atomic resolution have remained elusive mainly because of their extensive polymorphism and because their polymeric properties have hampered structural studies by classical approaches. Progress in sample preparation, as well as solid-state NMR methods, recently enabled the determination of high-resolution 3D structures of fibrils such as the amyloid-β fibril, which is involved in Alzheimer's disease. Notably, the simultaneous but independent structure determination of Aβ1-42, a peptide that forms fibrillar deposits in the brain of Alzheimer patients, by two independent laboratories, which yielded virtually identical results, has highlighted how structures can be obtained that allow further functional investigation.
原子分辨率的淀粉样结构仍然难以捉摸,主要是因为它们具有广泛的多态性,而且它们的聚合性质通过经典方法阻碍了结构研究。最近,在样品制备方面的进展以及固态 NMR 方法的发展,使得确定淀粉样蛋白-β纤维等原纤维的高分辨率 3D 结构成为可能,而淀粉样蛋白-β纤维与阿尔茨海默病有关。值得注意的是,两个独立的实验室同时但独立地确定了 Aβ1-42 的结构,Aβ1-42 是一种在阿尔茨海默病患者大脑中形成纤维状沉积物的肽,几乎得到了相同的结果,这突出表明可以获得允许进一步功能研究的结构。